Comparison of acute myocardial infarct size in patients ≥65 years versus <65 years in the prethrombolytic period versus the thrombolytic period

American Journal of Cardiology

Volumn 89, Issue 11, 2002, Pages 1291-1293

  Kloner, Robert A ^a,e   Poole, Ken ^c   Shook, Thomas ^a   Przyklenk, Karin ^a,b   Perritt, Kitty ^c   Cannon, Christopher P ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c RTI INTERNATIONAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORRELATION ANALYSIS; HEART INFARCTION SIZE; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE;

AGE FACTORS; AGED; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 0036607756     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02328-7     Document Type: Article

References (14)

1. Age and outcome with contemporary thrombolytic therapy. Results from GUSTO-Trial
2. Aging and the heart
3. Ischemic heart disease in the elderly: A need to understand the causes of high mortality after acute myocardial infarction
4. Elderly patients with acute coronary syndromes: Higher risk and greater benefit from antithrombotic and interventional therapies
5. Aging increases ischemia-reperfusion injury in the isolated buffer-perfused heart
6. + after ischemia
7. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria
8. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase, and combination of thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial
9. An improved basis for enzymatic estimation of infarct size
10. Estimation of infarct size with MB rather than total CK
11. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy
12. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: An InTIME II substudy
13. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients